The prolonged, contentious process that led to allowing OTC sales of emergency contraceptives in the US was “the adventure of a lifetime” for women’s reproductive rights advocate Kirsten Moore.
Asking the Food and Drug Administration for approval of an OTC daily oral contraceptive could be just as eventful, suggests Moore, executive director of the Expanding Medication Abortion Access Project nonprofit and previously CEO of the Reproductive Health Technologies
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?